Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1266989.RAi85DVBaCpwOESQv16YeDckSMcbqYOWkcTZceCoVmfKQ130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1266989.RAi85DVBaCpwOESQv16YeDckSMcbqYOWkcTZceCoVmfKQ130_assertion type Assertion NP1266989.RAi85DVBaCpwOESQv16YeDckSMcbqYOWkcTZceCoVmfKQ130_head.
- NP1266989.RAi85DVBaCpwOESQv16YeDckSMcbqYOWkcTZceCoVmfKQ130_assertion description "[Almost exactly 20 years after their discovery, the BRCA1 and BRCA2 genes have become the target of the first personalized therapy available for patients with ovarian cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1266989.RAi85DVBaCpwOESQv16YeDckSMcbqYOWkcTZceCoVmfKQ130_provenance.
- NP1266989.RAi85DVBaCpwOESQv16YeDckSMcbqYOWkcTZceCoVmfKQ130_assertion evidence source_evidence_literature NP1266989.RAi85DVBaCpwOESQv16YeDckSMcbqYOWkcTZceCoVmfKQ130_provenance.
- NP1266989.RAi85DVBaCpwOESQv16YeDckSMcbqYOWkcTZceCoVmfKQ130_assertion SIO_000772 25725131 NP1266989.RAi85DVBaCpwOESQv16YeDckSMcbqYOWkcTZceCoVmfKQ130_provenance.
- NP1266989.RAi85DVBaCpwOESQv16YeDckSMcbqYOWkcTZceCoVmfKQ130_assertion wasDerivedFrom befree-2016 NP1266989.RAi85DVBaCpwOESQv16YeDckSMcbqYOWkcTZceCoVmfKQ130_provenance.
- NP1266989.RAi85DVBaCpwOESQv16YeDckSMcbqYOWkcTZceCoVmfKQ130_assertion wasGeneratedBy ECO_0000203 NP1266989.RAi85DVBaCpwOESQv16YeDckSMcbqYOWkcTZceCoVmfKQ130_provenance.